20:41:34 EDT Wed 21 Aug 2019
Enter Symbol
or Name

Login ID:

News for U:EOLS from 2018-08-22 to 2019-08-21 - 35 items News ReleasesIn The NewsOther
2019-08-12 07:01EOLSNews ReleaseEvolus Reports Second Quarter 2019 Financial Results
2019-08-01 08:30EOLSNews ReleaseEvolus to Report Second Quarter 2019 Financial Results and Provide a Business Update  on Monday, August 12, 2019
2019-07-15 08:30EOLSNews ReleaseEvolus Expands Board of Directors with Appointment of Independent Directors Peter Farrell, Ph.D. and Karah Parschauer, J.D.
2019-06-10 09:00EOLSNews ReleaseEvolus Provides Update on Nuceiva ™ Marketing Authorization Application in Europe
2019-06-05 07:45EOLSNews ReleaseEvolus Accelerates Next Phase of U.S. Launch of Jeuveau ™ with ‘#NEWTOX NOW ’ Consumer Conversion Program
2019-05-28 16:01EOLSNews ReleaseEvolus to Participate in Three Upcoming Investor Conferences
2019-05-21 09:00EOLSNews ReleaseALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt
2019-05-15 16:58EOLSNews ReleaseALPHAEON Corporation sells 4 million shares in Evolus Inc.
2019-05-15 09:00EOLSNews ReleaseEvolus Announces First Shipment of Jeuveau ™ (prabotulinumtoxinA-xvfs) to Customers in the United States
2019-04-30 16:01EOLSNews ReleaseEvolus Reports First Quarter 2019 Financial Results
2019-04-29 08:00EOLSNews ReleaseEvolus to Participate in Two Upcoming Investor Conferences
2019-04-26 08:50EOLSNews ReleaseEvolus Receives Positive CHMP Opinion for Nuceiva ™ in the European Union
2019-04-24 16:05EOLSNews ReleaseEvolus to Release First Quarter 2019 Financial Results and Provide a Business Update on Tuesday, April 30, 2019
2019-04-08 08:10EOLSNews ReleaseRecent Analysis Shows Veritiv, Plains All American Pipeline, WESCO International, Evolus, Schnitzer Steel Industries, and Vornado Realty Trust Market Influences — Renewed Outlook, Key Drivers of Growth
2019-04-08 07:00EOLSNews ReleaseEvolus Announces Publication of Largest Aesthetic Head-to-Head Pivotal Trial Comparing Jeuveau ™ and BOTOX ® in Aesthetic Surgery Journal
2019-04-01 09:00EOLSNews ReleaseEvolus Provides Regulatory Update on Nuceiva ™ in the European Union
2019-03-21 08:00EOLSNews ReleaseEvolus Announces Publication of U.S. Phase III Pivotal Trial Results for Jeuveau ™ in Dermatologic Surgery
2019-03-18 16:04EOLSNews ReleaseEvolus Reports Fourth Quarter and Full Year 2018 Results
2019-03-18 16:01EOLSNews ReleaseEvolus Secures $100 Million Senior Debt Facility with Oxford Finance LLC
2019-03-15 16:01EOLSNews ReleaseEvolus to Release Fourth Quarter and Full Year 2018 Financial Results and Provide a Business Update on Monday, March 18, 2019
2019-02-27 09:00EOLSNews ReleaseEvolus Appoints Crystal Muilenburg as Vice President Corporate Communications & Public Relations
2019-02-04 06:00EOLSNews ReleaseEvolus to Hold Conference Call Following Jeuveau ™ FDA Approval
2019-02-01 16:58EOLSNews ReleaseEvolus Receives FDA Approval for Jeuveau ™ prabotulinumtoxinA-xvfs for Injection
2018-12-19 08:01EOLSNews ReleaseEvolus Added to NASDAQ Biotechnology Index
2018-12-11 07:50EOLSNews ReleaseInvestor Expectations to Drive Momentum within eBay, Pulse Biosciences, Evolus, Weibo, OptiNose, and The Descartes Systems Group — Discovering Underlying Factors of Influence
2018-12-03 09:25EOLSNews ReleaseALPHAEON repays outstanding principal amount under its secured convertible notes due December 23, 2018
2018-11-19 05:30EOLSNews ReleaseEvolus Receives Conditional FDA Acceptance of Jeuveau ™ Brand Name
2018-11-05 16:05EOLSNews ReleaseEvolus Reports Third Quarter 2018 Financial Results
2018-11-01 08:01EOLSNews ReleaseEvolus to Participate in Two Upcoming Investor Conferences
2018-10-22 16:01EOLSNews ReleaseEvolus Expands Leadership Team with Appointments of Key Executives
2018-10-22 08:10EOLSNews ReleaseDetailed Research: Economic Perspectives on Caseys General Stores, Evolus, OptiNose, Xunlei, Molina Healthcare, and Frontline — What Drives Growth in Today's Competitive Landscape
2018-10-18 08:01EOLSNews ReleaseEvolus to Release Third Quarter 2018 Financial Results on Monday, November 5, 2018
2018-09-20 16:01EOLSNews ReleaseEvolus to Present at the Cantor Global Healthcare Conference
2018-09-05 08:01EOLSNews ReleaseEvolus Appoints Ashwin K. Agarwal as Vice President, Finance, Investor Relations and Treasury
2018-08-29 08:01EOLSNews ReleaseEvolus Receives Acceptance of FDA BLA Resubmission for DWP-450